Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#
The study objective was to conduct Pharmacoeconomics study (cost-effective analysis) between infliximab reference (Remicade) and its biosimilar (Remsima) in patients with rheumatoid arthritis (RA) in Iraqi hospitals. This is a retrospective multicenter pharmacoeconomic analysis conducted at two...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
College of Pharmacy University of Baghdad
2023-02-01
|
| Serija: | Iraqi Journal of Pharmaceutical Sciences |
| Teme: | |
| Online dostop: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2033 |
| Oznake: |
Brez oznak, prvi označite!
|